Skip to main content
Toggle navigation
Login
Search
Home
Tweets by SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Presenter
Browse by Presenter
Browse by Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Saadat, Lily
Memorial Sloan Kettering Cancer Center
A3: Hepatic Arterial Infusion Pump Chemotherapy for Management of Unresectable Colorectal Liver Metastases with Extrahepatic Disease
Lily Saadat
A3: Q&A
Lily Saadat
Sabel, Michael
University of Michigan
Benefits of Survivorship for You and Your Patient
Michael Sabel
V54: Implementation Outcomes for Active Surveillance with Ultrasound (U/S) Following a Positive Sentinel Lymph Node (SLN) in Melanoma at an Academic Medical Center
Michael Sabel
Saif, Areeba
National Institutes of Health
75: Using an ex-vivo Human Tumor Platform to Perform Dynamic Live Tumor Imaging
Areeba Saif
75: Q&A
Areeba Saif
Sanders, Stacy
Mayo Clinic
19: Q&A
Stacy Sanders
19: Sentinel Lymph Node Metastasis Size and Tumor Biology Predict Non-sentinel Lymph Node Involvement After Neoadjuvant Chemotherapy for Breast Cancer
Stacy Sanders
Sarkar, Joy
Roswell Park Comprehensive Cancer Center
A44: Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Obstructive Jaundice
Joy Sarkar
A44: Q&A
Joy Sarkar
A47: Intratumoral Density of Regulatory T Cells Is a Predictor of Host Immune Response and Chemotherapy Response Rate in Metastases from Colorectal Cancer
Joy Sarkar
A47: Q&A
Joy Sarkar
Satyananda, Vikas
Kaiser Permanente Los Angeles Medical Center
69: Q&A
Vikas Satyananda
69: Robot Assisted Transgastric Resection of Leiomyoma at Gastroesophageal Junction
Vikas Satyananda
Sbaity, Eman
Global Partner Posters Grand Rounds: On-Demand Pre-Recording
Eman Sbaity
Scally, Christopher
University of Texas MD Anderson Cancer Center
Improving Surgical Outcomes Through Frailty Assessment and Prehabilitation
Christopher Scally
Scheri, Randall
Duke University
Management of Challenging Thyroid Cancer
Randall Scheri
Schiffman, Suzanne
Allegheny Health Network
Presentation
Suzanne Schiffman
Schwartz, Patrick
University of Wisconsin, Madison
A36: Q&A
Patrick Schwartz
A36: Rethinking Routine Intensive Care Following Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: The Fiscal Argument
Patrick Schwartz
Senders, Zachary
University of Louisville
52: Q&A
Zachary Senders
52: Stage Migration as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma
Zachary Senders
Senthil, Maheswari
University of California, Irvine
ACT: Applied Research Abstract Presentations
Maheswari Senthil
Global Partner Posters Grand Rounds: On-Demand Pre-Recording
Maheswari Senthil
Seo, Yongwoo
MD Anderson Cancer Center
62: Intratumoral Injection of the Toll-like Receptor 4 Agonist G100 Induces Durable Local Control and Causes Immune Activation in the Tumor Microenvironment in Metastatic Soft Tissue Sarcomas
Yongwoo Seo
62: Q&A
Yongwoo Seo
Shaha, Ashok
Memorial Sloan Kettering Cancer Center
Virtual Endocrine Great Debate: Is Observation an Acceptable Management for Well Differentiated Thyroid Cancer?
Ashok Shaha
Shah, Manan
Basavatarakam Indo American Cancer Hospital and Research Institute
Global Partner Posters Grand Rounds: On-Demand Pre-Recording
Manan Shah
Shah, Shimul
University of Cincinnati College of Medicine
Bridging Therapies Prior to Transplant for HCC: Is There a Gold Standard?
Shimul Shah
Liver Transplantion for Colorectal Liver Metastases (Pro)
Shimul Shah
Rebuttals, Post-questions and Discussion
Shimul Shah
Shannon, Adrienne
Hospital of the University of Pennsylvania
50: Q&A
Adrienne Shannon
50: Sentinel Lymph Node Biopsy in Patients with t1a Cutaneous Malignant Melanoma
Adrienne Shannon
Sharib, Jeremy
Department of Surgery
A4: Perioperative and Oncologic Outcomes of Hepatic Artery Infusion Pump Therapy at an Expanding HAI Program
Jeremy Sharib
A4: Q&A
Jeremy Sharib
Sheldon, Yarrow
Christiana Care
AP17 Review of safety data for Adenovirus 5 (Ad5) as a delivery vector for intratumoral cancer gene therapy
Yarrow Sheldon
Shia, Jinru
Pathology of Appendiceal Mucinous Neoplasms
Jinru Shia
Shibata, David
University of Tennessee Health Science Center
Colorectal Great Debate: Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
David Shibata
Shoup, Margo
Orlando Health Cancer Institute
Hiring in a Community-based Program
Margo Shoup
Sibia, Udai
Anne Arundel Medical Center
15: Oncotypedx Testing Does Not Appear to Benefit Patients with Grade 1, Progesterone Receptor Positive Breast Cancers: A Tailorx Validated Study
Udai Sibia
15: Q&A
Udai Sibia
Sicklick, Jason
UC San Diego Moores Cancer Center
Molecular Profiling to Personalize Therapies for Advanced Cancer: Successes, Failures, and Current Trials
Jason Sicklick
Siegel, Emily
Keck School of Medicine of USC
Intraoperative Margin Assessment for Breast Cancer
Emily Siegel
Silva, Jeronimo
Hospital do Cancer de Pernambuco
Global Partner Posters Grand Rounds: On-Demand Pre-Recording
Jeronimo Silva
Silver, Casey
Northwestern University
V45: Neoadjuvant Therapy in Extrahepatic Cholangiocarcinoma: Improved Outcomes or Just Rearranging the Deck Chairs?
Casey Silver
Singal, Amit
University of Texas Southwestern Medical Center
Immunotherapy and HCC: Not Just for Advanced HCC
Amit Singal
Singer, Samuel
Memorial Sloan Kettering Cancer Center
CONCUR – There Is No Indication for Radiation Therapy
Samuel Singer
Sinnamon, Andrew
Moffitt Cancer Institute
V48: Risk Assessment and Stratification for Hepatic Resection with Simultaneous Visceral Resection
Andrew Sinnamon
V80: Tumor Regression Grade and Overall Survival Following Gastrectomy with Neoadjuvant Therapy for Gastric Cancer
Andrew Sinnamon
Skitzki, Joseph
Roswell Park Comprehensive Cancer Center
A45: Early Observations from Clinical Trial of Intra-arterial Curaxin CBL0137
Joseph Skitzki
A45: Q&A
Joseph Skitzki
ACT: Applied Research Abstract Presentations
Joseph Skitzki
Introductions and Case Study Presentations
Joseph Skitzki
Neoadjuvant Immunotherapy
Joseph Skitzki
Tumor Board: Neoadjuvant Immunotherapy and TVEC for Melanoma
Joseph Skitzki
Smith, J. Joshua
Memorial Sloan Kettering Cancer Center
Long-term Surveillance and Timing of Surgery for Regrowth
J. Joshua Smith
Snyder, Rebecca
Brody School of Medicine at East Carolina University
How Can Molecular Analysis Resolve Dilemmas in IPMN Management?
Rebecca Snyder
Prehabilitation: Who Should Undergo Prehab and What Is the Best Intervention?
Rebecca Snyder
Solórzano, Carmen
Vanderbilt University Medical Center
Auto-fluorescence Probe Based Identification
Carmen Solórzano
Case Presentation
Carmen Solórzano
Solsky, Ian
Wake Forest
A37: Q&A
Ian Solsky
A37: Survival Outcomes of Optimally-treated Colorectal Metastases: The Importance of R0 Status in Hepatic and Peritoneal Surface Disease
Ian Solsky
AP9 Opioid and Psychotropic Medication Use in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients
Ian Solsky
Sonal, Swati
Massachusetts General Hospital
V28: Molecular Basis of Extramural Vascular Invasion (EMVI) Positive Colorectal Carcinoma
Swati Sonal
Sondak, Vernon
Moffitt Cancer Center
SLN Biopsy Should Not Be Offered to Patients with Clinical Stage IIB/C Melanoma (Con)
Vernon Sondak
Soran, Atilla
UPMC
Introductions
Atilla Soran
Q&A and Discussion
Atilla Soran
Virtual Breast Session: Locoregional Management for Stage IV Breast Cancer
Atilla Soran
Sparano, Joseph
Icahn School of Medicine at Mount Sinai
Locoregional Management: Presentation 3
Joseph Sparano
Q&A and Discussion
Joseph Sparano
Spielbauer, Katie
Michigan Medicine
46: C-terminal hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma
Katie Spielbauer
46: Q&A
Katie Spielbauer
Spitz, Francis
Cooper University Hospital
Great Debate: Immunotherapy for GI Malignancy. Is It Primetime?
Francis Spitz
Srour, Marissa
Memorial Sloan Kettering Cancer Center
V20: Who Are We Missing: Does Engagement in Patient Reported Outcome Measures (PROM) for Breast Cancer Vary by Age, Race, and Disease Stage?
Marissa Srour
Stafford, Arielle
Mayo Clinic
7: Factors Associated with Axillary Dissection in Breast Conserving Surgery or Mastectomy for ct1-2n0 Breast Cancer with 1-2 Positive Sentinel Lymph Node(s)
Arielle Stafford
7: Q&A
Arielle Stafford
Staley, Charles
Emory
ACT 2022 Chair Lecture: ACT: Surgeons Leading Therapeutic Clinical Trials: An Opportunity for Multi-disciplinary Collaboration
Charles Staley
ACT 2022 Welcome
Charles Staley
Stewart, Camille
University of Colorado School of Medicine
Skin Cancer Tumor Board: (2 Cases – Melanoma, Merkel Cell Carcinoma)
Camille Stewart
Virtual Melanoma Great Debate: SLN Biopsy Should Not Be Offered to Patients with Clinical Stage IIB/C Melanoma
Camille Stewart
Stiles, Zachary
Roswell Park Comprehensive Cancer Institute
V79: The Utility and Relevance of Subcarinal Lymph Node Dissection During Minimally Invasive Esophagectomy for Gastroesophageal Junction Tumors
Zachary Stiles
Stitzenberg, Karyn
University of North Carolina at Chapel Hill
Extended and Multivisceral Resections for Colorectal Cancer: indications, Technique and Outcome
Karyn Stitzenberg
Indications of Local Excision
Karyn Stitzenberg
Straker, Richard
University of Pennsylvania, Perelman School of Medicine
V56: Prognostic Significance of Tumor Infiltrating Lymphocytes in a Contemporary Melanoma Cohort
Richard Straker
Strijbos, Bo
Máxima Medical Centre
Global Partner Posters Grand Rounds: On-Demand Pre-Recording
Bo Strijbos
Sturgeon, Cord
Northwestern University
Is Observation an Acceptable Management Option for Well Differentiated Thyroid Cancer? (Con)
Cord Sturgeon
Sucandy, Iswanto
AdventHealth Tampa
71: Q&A
Iswanto Sucandy
74: Q&A
Iswanto Sucandy
74: Techniques and Outcomes of Robotic Resection for Perihilar & Extrahepatic Cholangiocarcinoma Requiring Biliary Reconstruction
Iswanto Sucandy
Sullivan, Brittany
University of California - Irvine General Surgery
A19: Circulating Tumor DNA Is Unreliable to Detect Somatic Gene Alterations in Gastrointestinal Peritoneal Carcinomatosis
Brittany Sullivan
A19: Q&A
Brittany Sullivan
A34: Peritoneal Carcinomatosis Vascularized Micro-tumor (VMT) as a Platform for Drug Testing
Brittany Sullivan
A34: Q&A
Brittany Sullivan
Sullivan, Kevin
City of Hope
60: Q&A
Kevin Sullivan
60: The Hidden Costs of Medicare Advantage: Association with Limited Access to High-volume Complex Cancer Surgery and Detriment in Long-term Survival
Kevin Sullivan
76: A Unique Immunosuppressive Macrophage Transcriptional Signature Is a Poor Prognostic Biomarker in Primary Upper GI Cancer
Kevin Sullivan
76: Q&A
Kevin Sullivan
AP14 Multicenter Dose Escalation Phase 1 trial of Mitomycin C Pressurized Intraperitoneal Aerosolized Chemotherapy in Combination with Systemic Chemotherapy for Appendiceal and Colorectal Carcinomatosis
Kevin Sullivan
Sun, Steven
Ohio State University
V51: Characterization of Peroxynitrite Generation by Myeloid Derived Suppressor Cells in Patients with Advanced Melanoma
Steven Sun
Suraju, Mohammed
University of Iowa Hospitals and Clinics
V22: Conditional Survival After Total Neoadjuvant vs Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Mohammed Suraju
Sutton, Thomas
Oregon Health and Science University
55: A Perioperative Bundle for Reduction of Incisional Surgical Site Infections Following Pancreaticoduodenectomy: A Pre-post Intervention Study
Thomas Sutton
55: Q&A
Thomas Sutton
Swallow, Carol
University of Toronto
DISSENT – There Is Indication for Radiation
Carol Swallow
Swinarska, Joanna
Milton S. Hershey Medical Center
70: Q&A
Joanna Swinarska
70: Robotic Excision of a Type I Choledochal Cyst with Roux-en-y Hepaticojejunostomy
Joanna Swinarska
Back to Top
